Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Technology

GoPro announces major restructuring plan including 23% global workforce reduction

GoPro (NASDAQ:GPRO) announced on April 7, 2026, that its Board of Directors has approved a comprehensive restructuring plan designed to significantly reduce operating costs and accelerate the company’s push toward stronger operating leverage.

Leia mais: GoPro announces major restructuring plan including 23% global workforce reduction
Grafa
Energy

SolarMax Technology reports record 296% revenue growth driven by massive BESS expansion

SolarMax Technology (NASDAQ:SMXT), a leading integrated solar energy company, announced record financial results for the fiscal year ended December 31, 2025, marked by a near-fourfold increase in revenue and a significant expansion of its energy storage pipeline.

Leia mais: SolarMax Technology reports record 296% revenue growth driven by massive BESS expansion
Grafa

Lexaria Bioscience welcomes FDA approval of Eli Lilly’s Foundayo as oral GLP-1 market expands

Lexaria Bioscience (NASDAQ:LEXX), a global innovator in drug delivery platforms, issued a statement on April 7, 2026, applauding the U.S. Food and Drug Administration (FDA) approval of Eli Lilly’s Foundayo, the latest oral GLP-1 receptor agonist for chronic weight management in adults.

Leia mais: Lexaria Bioscience welcomes FDA approval of Eli Lilly’s Foundayo as oral GLP-1 market expands
Grafa
Technology

TransDigm finalizes $2.2B acquisition of Jet Parts Engineering and Victor Sierra Aviation

TransDigm Group (NYSE:TDG), a leading global designer, producer, and supplier of highly engineered aircraft components, announced on April 7, 2026, the successful completion of its acquisition of Jet Parts Engineering and Victor Sierra Aviation Holdings for approximately $2.2 billion in cash.

Leia mais: TransDigm finalizes $2.2B acquisition of Jet Parts Engineering and Victor Sierra Aviation
Grafa

Savara secures accelerated review in the UK for autoimmune PAP therapy MOLBREEVI

Savara (NASDAQ:SVRA), a clinical-stage biopharmaceutical company dedicated to rare respiratory diseases, announced on April 7, 2026, that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has accepted its Marketing Authorisation Application (MAA) for MOLBREEVI.

Leia mais: Savara secures accelerated review in the UK for autoimmune PAP therapy MOLBREEVI
Grafa

Gilead to acquire Tubulis for $5B to accelerate next-generation cancer therapies

Gilead Sciences (NASDAQ:GILD) announced on April 7, 2026, that it has entered into a definitive agreement to acquire Tubulis GmbH, a private German biotechnology company specializing in next-generation antibody-drug conjugates (ADCs).

Leia mais: Gilead to acquire Tubulis for $5B to accelerate next-generation cancer therapies
Grafa

Jaguar Health reports Q4 2025 results and highlights $16M strategic cash infusion

Jaguar Health (NASDAQ:JAGX), a commercial-stage pharmaceutical company focused on gastrointestinal products, released its consolidated financial results for the fourth quarter and full year ended December 31, 2025, on April 7, 2026.

Leia mais: Jaguar Health reports Q4 2025 results and highlights $16M strategic cash infusion